NZ222083A - Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose - Google Patents

Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose

Info

Publication number
NZ222083A
NZ222083A NZ222083A NZ22208387A NZ222083A NZ 222083 A NZ222083 A NZ 222083A NZ 222083 A NZ222083 A NZ 222083A NZ 22208387 A NZ22208387 A NZ 22208387A NZ 222083 A NZ222083 A NZ 222083A
Authority
NZ
New Zealand
Prior art keywords
composition according
hydroxypropyl methylcellulose
microcrystalline cellulose
acetylsalicylic acid
asa
Prior art date
Application number
NZ222083A
Other languages
English (en)
Inventor
Henry C Gan
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ222083A publication Critical patent/NZ222083A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
NZ222083A 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose NZ222083A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
NZ222083A true NZ222083A (en) 1991-05-28

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ222083A NZ222083A (en) 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose

Country Status (24)

Country Link
JP (1) JPS63101334A (de)
KR (1) KR880004801A (de)
AU (1) AU7942087A (de)
BE (1) BE1000732A5 (de)
CA (1) CA1332809C (de)
CH (1) CH675831A5 (de)
DE (1) DE3733540A1 (de)
DK (1) DK527487A (de)
ES (1) ES2014518A6 (de)
FI (1) FI874414A (de)
FR (1) FR2604902B1 (de)
GB (2) GB8624213D0 (de)
GR (1) GR871550B (de)
HU (1) HU201875B (de)
IL (1) IL84104A0 (de)
IT (1) IT1221493B (de)
LU (1) LU87009A1 (de)
NL (1) NL8702294A (de)
NO (1) NO874200L (de)
NZ (1) NZ222083A (de)
PH (1) PH24227A (de)
PT (1) PT85880B (de)
SE (1) SE8703889L (de)
ZA (1) ZA877617B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
IL145661A0 (en) * 1999-03-31 2002-06-30 Janssen Pharmaceutica Nv Pregelatinized starch in a controlled release formulation
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
DK1803447T3 (da) * 2004-09-09 2009-10-12 Psicofarma S A De C V Farmaceutisk sammensætning til vedvarende frisætning af hydralazin og anvendelse heraf som en understötning for cancerbehandling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제

Also Published As

Publication number Publication date
HU201875B (en) 1991-01-28
GB8624213D0 (en) 1986-11-12
GB8723515D0 (en) 1987-11-11
LU87009A1 (fr) 1988-05-03
GR871550B (en) 1988-02-15
PT85880B (pt) 1990-07-31
CH675831A5 (de) 1990-11-15
GB2195893A (en) 1988-04-20
PT85880A (en) 1987-11-01
DK527487A (da) 1988-04-10
CA1332809C (en) 1994-11-01
SE8703889L (sv) 1988-04-10
BE1000732A5 (fr) 1989-03-21
FI874414A (fi) 1988-04-10
IT1221493B (it) 1990-07-06
ZA877617B (en) 1989-05-30
HUT52958A (en) 1990-09-28
FR2604902A1 (fr) 1988-04-15
KR880004801A (ko) 1988-06-27
IL84104A0 (en) 1988-03-31
NO874200L (no) 1988-04-11
PH24227A (en) 1990-05-04
NO874200D0 (no) 1987-10-07
DK527487D0 (da) 1987-10-08
ES2014518A6 (es) 1990-07-16
GB2195893B (en) 1991-05-08
JPS63101334A (ja) 1988-05-06
FR2604902B1 (fr) 1991-04-26
DE3733540A1 (de) 1988-04-14
IT8748469A0 (it) 1987-10-08
FI874414A0 (fi) 1987-10-07
SE8703889D0 (sv) 1987-10-08
AU7942087A (en) 1988-04-14
NL8702294A (nl) 1988-05-02

Similar Documents

Publication Publication Date Title
EP1058538B2 (de) Schnell zerfallende tablette
JP3037757B2 (ja) パロキセチン錠およびその製法
PT1351668E (pt) Formas de dosagem farmacêutica de libertação sustida com perfis de dissolução dependentes de ph minimizado
AU2002249881A1 (en) Sustained release pharmaceutical dosage forms with minimized PH dependent dissolution profiles
JPH07558B2 (ja) モピダモール製剤
JPH03200724A (ja) 二重作用錠剤
AU721851B2 (en) Swallow tablet comprising paracetamol
CA2182004C (en) Film coated tablet of paracetamol and domperidone
EP1112065A1 (de) Pharmazeutische zusammensetzung enthaltend entacapon oder nitecapon sowie ein vernetztes cellulosederivat
NZ222083A (en) Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose
EP1392271B1 (de) Paracetamol enthaltende tablette
MXPA06015095A (es) Formulacion oral de liberacion sostenida de tedisamil con propiedades de retencion gastrica.
ES2614757T3 (es) Nueva composición de alfentanilo para el tratamiento del dolor agudo
AU2002317772A1 (en) Swallow tablet comprising paracetamol
JPH0757726B2 (ja) 高分子量ヒドロキシプロピルメチルセルロースを基剤にした徐放性錠剤
JP2023071921A (ja) 様々な用量のレナリドミドの経口用錠剤組成物
TW200304807A (en) Sleeping medicine formed by coating solid
KR101046789B1 (ko) 안정성이 개선된 암로디핀 속붕해성 정제 및 그의 제조방법
JP4999297B2 (ja) 高含量塩酸テルビナフィン小型錠剤
NZ207768A (en) Sustained release tablets comprising dipyridamole
Naik et al. Development of single unit floating-pulsatile site specific drug delivery system for chronotherapeutic release of aceclofenac
WO2005065662A1 (en) Solid dosage formulations of galantamine
WO1998042310A2 (en) Fast release compressed tablet of flurbiprofen
JP2023163350A (ja) チュアブル錠又は口腔内崩壊錠
WO2009063484A2 (en) Stable pharmaceutical composition of lamotrigine